{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:52:35Z","timestamp":1770976355977,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012739","name":"Zogenix","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.yebeh.2019.06.021","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T05:41:56Z","timestamp":1562737316000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"PA","title":["Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature"],"prefix":"10.1016","volume":"98","author":[{"given":"Susanne","family":"Schubert-Bast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelheid","family":"Wiemer-Kruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"von Spiczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Trollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp S.","family":"Reif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Polster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd A.","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Kurlemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kieslich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Kalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arne","family":"Herting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Bettendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.06.021_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52 Suppl 2","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0010","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0015","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1111\/epi.12927","article-title":"The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009","volume":"56","author":"Bayat","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.yebeh.2017.08.029","article-title":"Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet syndrome","volume":"78","author":"Nabbout","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.seizure.2016.10.014","article-title":"From genotype to phenotype in Dravet disease","volume":"44","author":"Gataullina","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1528-1167.2009.02466.x","article-title":"A long-term follow-up study of Dravet syndrome up to adulthood","volume":"51","author":"Akiyama","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0035","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/epi.14729","article-title":"Burden and epidemiology of status epilepticus in infants, children, and adolescents: a population-based study on German health insurance data","volume":"60","author":"Schubert-Bast","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American Consensus Panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10309-018-0236-4","article-title":"Treatment of Dravet syndrome","volume":"32","author":"Von Spiczak","year":"2019","journal-title":"Z Epileptol"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/epi.14191","article-title":"Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes","volume":"59","author":"de Lange","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0055","first-page":"1638","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial","volume":"356","author":"Chiron","year":"2000","journal-title":"STICLO study group Lancet"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yebeh.2014.12.028","article-title":"The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome","volume":"44","author":"Aras","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yebeh.2017.06.031","article-title":"Dravet syndrome: characteristics, comorbidities, and caregiver concerns","volume":"74","author":"Villas","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpn.2019.02.014","article-title":"Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: a prospective, multicenter study from Germany","volume":"23","author":"Strzelczyk","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0080","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/epi.13089","article-title":"Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany","volume":"56","author":"Riechmann","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.seizure.2019.03.016","article-title":"Quality of life and correlating factors in children, adolescents with epilepsy, and their caregivers: a cross-sectional multicenter study from Germany","volume":"69","author":"Riechmann","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/dmcn.13591","article-title":"Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey","volume":"60","author":"Lagae","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.12.018","article-title":"Caregiver impact and health service use in high and low severity Dravet syndrome: a multinational cohort study","volume":"65","author":"Lagae","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yebeh.2014.03.014","article-title":"Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam","volume":"34","author":"Strzelczyk","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/dmcn.13704","article-title":"Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study","volume":"60","author":"Myers","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0120","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/epi.13088","article-title":"Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic\u2013clonic seizures","volume":"56","author":"Kay","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16099","article-title":"A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany","author":"Strzelczyk","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1307454","article-title":"Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome","volume":"43","author":"Lotte","year":"2012","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0387-7604(88)80098-6","article-title":"Bromides were effective in intractable epilepsy with generalized tonic\u2013clonic seizures and onset in early childhood","volume":"10","author":"Ernst","year":"1988","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0140","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1528-1157.1994.tb01780.x","article-title":"Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant","volume":"35","author":"Oguni","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.braindev.2008.03.002","article-title":"Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)\u2014a nationwide questionnaire survey in Japan","volume":"30","author":"Tanabe","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2019.06.021_bb0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2016.05.012","article-title":"Patients with Dravet syndrome in the era of stiripentol: a French cohort cross-sectional study","volume":"125","author":"De Liso","year":"2016","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501930438X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501930438X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:28:27Z","timestamp":1761503307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501930438X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"alternative-id":["S152550501930438X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.021","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure management and prescription patterns of anticonvulsants in Dravet syndrome: A multicenter cohort study from Germany and review of literature","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}